| CRISPR/Cas9–An evolving biological tool kit for cancer biology and oncology X Tian, T Gu, S Patel, AM Bode, MH Lee, Z Dong NPJ precision oncology 3 (1), 8, 2019 | 103 | 2019 |
| Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer X Tian, T Gu, MH Lee, Z Dong Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (1), 188645, 2022 | 79 | 2022 |
| Cytokine signature induced by SARS-CoV-2 spike protein in a mouse model T Gu, S Zhao, G Jin, M Song, Y Zhi, R Zhao, F Ma, Y Zheng, K Wang, ... Frontiers in immunology 11, 621441, 2021 | 59 | 2021 |
| A small molecule antagonist of PD-1/PD-L1 interactions acts as an immune checkpoint inhibitor for NSCLC and melanoma immunotherapy Y Wang, T Gu, X Tian, W Li, R Zhao, W Yang, Q Gao, T Li, JH Shim, ... Frontiers in immunology 12, 654463, 2021 | 29 | 2021 |
| Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer X Tian, R Wang, T Gu, F Ma, KV Laster, X Li, K Liu, MH Lee, Z Dong Molecular Cancer 21 (1), 193, 2022 | 22 | 2022 |
| Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3 Y Hu, F Liu, X Jia, P Wang, T Gu, H Liu, T Liu, H Wei, H Chen, J Zhao, ... Oncogene 40 (23), 3942-3958, 2021 | 17 | 2021 |
| Expression of PTEN‐long mediated by CRISPR/Cas9 can repress U87 cell proliferation N Fang, T Gu, Y Wang, S Wang, F Wang, Y An, W Wei, W Zhang, X Guo, ... Journal of Cellular and Molecular Medicine 21 (12), 3337-3346, 2017 | 13 | 2017 |
| Acetylshikonin inhibits inflammatory responses and Papain-like protease activity in murine model of COVID-19 N Lu, T Gu, X Tian, S Zhao, G Jin, F Mangaladoss, Y Qiao, K Liu, R Zhao, ... Signal Transduction and Targeted Therapy 7 (1), 371, 2022 | 7 | 2022 |
| Molecular mechanism of SARS-CoV-2 components caused ARDS in murine model T Gu, S Zhao, G Jin, M Song, Y Zhi, R Zhao, F Ma, Y Zheng, K Wang, ... Biorxiv, 2020.06. 07.119032, 2020 | 4 | 2020 |
| Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint T Gu, X Tian, Y Wang, W Yang, W Li, M Song, R Zhao, M Wang, Q Gao, ... Frontiers in Immunology 14, 1145028, 2023 | 3 | 2023 |
| COVID-19 and strategies for its therapeutics F Ma, T Gu, S Zhao, K Liu, Z Dong Critical Reviews™ in Immunology 40 (6), 2020 | 2 | 2020 |
| The phosphatase of regenerating liver-3 protein (PRL-3) promotes glioma cell invasiveness by interacting with β3–tubulin Z Ge, T Gu, L Zhang, Q Fan, L Ma, N Fang Bioengineered 13 (2), 4112-4121, 2022 | 1 | 2022 |
| Characterization of lamin b receptor of Sf9 cells and its fate during autographa californica nucleopolyhedrovirus infection W Wei, Z Hu, Y Jia, TX Gu, W Zhao, S Ji Cytotechnology 72, 315-325, 2020 | 1 | 2020 |
| Cover Image, Volume 63, Issue 5 M Song, Y Qu, H Jia, Y Zhang, S Liu, KV Laster, BY Choi, J Tian, T Gu, ... Molecular Carcinogenesis 63 (5), i-i, 2024 | | 2024 |
| Intratumoural delivery of TRAIL mRNA induces colon cancer cell apoptosis T Gu, M Wang, X Fu, X Tian, J Bi, N Lu, C Chen, S Yan, A Li, L Wang, X Li, ... Biomedicine & Pharmacotherapy 174, 116603, 2024 | | 2024 |
| Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo M Song, Y Qu, H Jia, Y Zhang, S Liu, KV Laster, BY Choi, J Tian, T Gu, ... Molecular Carcinogenesis 63 (5), 991-1008, 2024 | | 2024 |
| A quantitative method for measuring the transfection efficiency of CD19-directed chimeric antigen receptor in target cells N Fang, N Zhong, T Gu, Y Wang, X Guo, S Ji Advances in Clinical and Experimental Medicine 28 (2), 159-164, 2019 | | 2019 |
